Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Visceral Leishmaniasis”

65 trials

Showing 20 of 65 results

Not applicableUnknownNCT05426577
What this trial is testing

Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 60
Post-approval studies (Phase 4)Study completedNCT01032187
What this trial is testing

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 101
Not applicableStudy completedNCT03646981
What this trial is testing

Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

Who this might be right for
Leishmaniasis, Visceral
Foundation for Innovative New Diagnostics, Switzerland 704
Not applicableStudy completedNCT05449717
What this trial is testing

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Who this might be right for
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Epicentre 52
Not applicableStudy completedNCT01069198
What this trial is testing

A Community Trial for Visceral Leishmaniasis (VL)

Who this might be right for
Visceral Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 200
Large-scale testing (Phase 3)Study completedNCT03129646
What this trial is testing

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 439
Large-scale testing (Phase 3)Study completedNCT00216346
What this trial is testing

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
PATH 667
Large-scale testing (Phase 3)Study completedNCT00628719
What this trial is testing

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 400
Testing effectiveness (Phase 2)WithdrawnNCT01437020
What this trial is testing

SCH708980 With and Without AmBisome for Visceral Leishmaniasis

Who this might be right for
LeishmaniasisEffects of Immunotherapy
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Ended earlyNCT01980199
What this trial is testing

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 14
Early research (Phase 1)Study completedNCT02071758
What this trial is testing

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Visceral Leishmaniasis
Access to Advanced Health Institute (AAHI) 39
Testing effectiveness (Phase 2)Study completedNCT01067443
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 151
Testing effectiveness (Phase 2)Study completedNCT02431143
What this trial is testing

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 30
Not applicableActive Not RecruitingNCT04342715
What this trial is testing

Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
University of York 216
Testing effectiveness (Phase 2)Ended earlyNCT00378495
What this trial is testing

Miltefosine for Brazilian Visceral Leishmaniasis

Who this might be right for
Kala Azar
AB Foundation 80
Testing effectiveness (Phase 2)Study completedNCT00381394
What this trial is testing

A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.

Who this might be right for
Leishmaniasis, Visceral
GlaxoSmithKline 61
Not applicableStudy completedNCT06977490
What this trial is testing

Human Bioequivalence Study of Amphotericin B Liposome for Injection

Who this might be right for
Invasive Fungal InfectionsNeutropenic FeverVisceral Leishmaniasis
Sichuan Huiyu Pharmaceutical Co., Ltd 42
Not applicableLooking for participantsNCT04020536
What this trial is testing

Real World Study of Classic Infectious Disease

Who this might be right for
BrucellosesEpidemic Hemorrhagic FeverKala-Azar
Huashan Hospital 10,000
Large-scale testing (Phase 3)Study completedNCT00696969
What this trial is testing

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 634
Post-approval studies (Phase 4)Study completedNCT00604955
What this trial is testing

Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
PATH 2,000
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation